VolitionRx Limited
VNRX · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 59.1% | 153% | 240.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,073.6% | -4,390.8% | -9,541.8% | -28,532% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,186.3% | -4,555.5% | -9,879.1% | -29,782.5% |
| EPS Diluted | -0.31 | -0.5 | -0.55 | -0.51 |
| % Growth | 38% | 9.1% | -7.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |